Optimapharm Lithuania UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
819,964 |
53,592 |
31,572 |
25,841 |
1,689 |
0.25 |
0.35 |
15.42 |
3.15 |
204,738 |
72,010 |
0 |
276,705 |
2022 |
---|
743,587 |
50,208 |
28,459 |
23,508 |
1,587 |
0.31 |
0.45 |
13.48 |
3.16 |
228,246 |
101,685 |
0 |
329,722 |
2023 |
---|
1,020,985 |
69,172 |
56,423 |
36,814 |
2,494 |
0.24 |
1.00 |
15.25 |
3.61 |
265,060 |
264,334 |
706 |
507,249 |
Register and
explore Okredo data2023 |
---|
1,020,985 |
69,172 |
56,423 |
36,814 |
2,494 |
0.24 |
1.00 |
15.25 |
3.61 |
265,060 |
264,334 |
706 |
507,249 |
Register and
explore Okredo data2023
Turnover (€)
1,020,985 €37 % *
Sales per employee (€)
69,172 €38 % *
Profit before tax (€)
56,423 €98 % *
Net Profit (€)
36,814 €57 % *
Profit per employee (€)
2,494 €57 % *
Working capital requirement
0.24 -22.58 % *
Debt-to-equity ratio
1.00 122.22 % *
Total profitability (%)
15.25 %13.13 % *
Net profitability (%)
3.61 %14.24 % *
Equity (€)
265,060 €16 % *
Amounts Payable And Liabilities (€)
264,334 €160 % *
Non-current Assets (€)
706 €- *
CurrentAssets (€)
507,249 €54 % *